Delhi HC Grants More Time For Central Govt To File Counter-Affidavits In All Matters On FDC Ban
New Delhi : The Division Bench of Delhi High Court, which is hearing the petitions by pharmaceutical manufacturers against the Central government’s order prohibiting 14 fixed dose combinations (FDCs) has…
Advisor Bhatnagar Reviews Performance, Functioning Of JKDFCO
Srinagar : Advisor to Lieutenant Governor, Rajeev Rai Bhatnagar today chaired a meeting and held a comprehensive review of the performance and functioning of J&K Drugs and Food Control Organisation…
21 Tata Hospital Staffers Booked For Referring Cancer Patients To Private Lab For Commission
Mumbai : 21 TATA hospital staffers booked for allegedly referring poor patients to a Parel-based private lab for various medical tests to pocket commissions, police said Tuesday. The police have booked…
Portal To Collate Data On Spurious Drugs In Works
New Delhi : India’s drug regulatory organization is planning to launch a unified portal to develop a digital drugs regulatory system. The system will maintain a database of drugs that are…
Suicidal Thoughts, Attempts Common Among Patients Starting Buprenorphine: Study
Philadelphia : There is a high prevalence of suicidal thoughts and attempts among patients with opioid use disorder (OUD) initiating buprenorphine, according to a study published online June 1 in Addiction Science…
Spurious Drugs Case: Baddi Firm Owner Fails To Join Probe
Solan : Mukesh Saini, proprietor of Magnatek Enterprises, a pharmaceutical firm allegedly involved in the production of spurious drugs, failed to join the investigation at Baddi today. The authorities sealed…
DCGI Issues Drug Alert On Usage Of Cough And Cold Medicine Pholcodine
New Delhi : The Drugs Controller General (India) (DCGI) has issued an advisory to the doctors, healthcare professionals and consumers to stop usage of opioid medicine pholcodine, which is used in…
TS Pharma Firm Penalised Rs 45 Lakh For Pollution
Hyderabad: The Telangana State Pollution Control Board (TSPCB) has imposed an environmental compensation penalty of Rs 45 lakh on Brundavan Laboratories, a pharmaceutical company, for violating environmental regulations. The pharmaceutical…
Poisoned Cough Syrup Traced To India Reveals Lapses In Regulation
New Delhi : Ebrima Sagnia was frantic as he carried his son through the doors of a hospital one evening last September. A few days earlier, Lamin had been a rambunctious…
FDI equity inflow into pharma sector registers growth of 45% in FY 23 to cross $2 billion mark
The Foreign Direct Investment (FDI) equity inflow into the pharmaceutical industry has registered a growth of 45.4 per cent in the fiscal year ended March, 2023, as compared to the…
